ProMetic Life Sciences has selected Alpha1-Antitrypsin (AAT) as its second plasma-derived therapeutic to develop and commercialise the product to address AAT deficiency. The company's PPPS process confirmed to produce AAT with three-fold ...
ProMetic Life Sciences and NantPharma have together formed an affiliate company, NantPro BioSciences, to develop and commercialize a plasma-derived biopharmaceutical product for the US market. The new US based company has entered into ...
Tags: affiliate company, plasma-derived biopharmaceutical product